Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen.

[1]  R. Bhat,et al.  A precore‐defective mutant of hepatitis B virus associated with e antigen‐negative chronic liver disease , 1990, Journal of medical virology.

[2]  C. Trépo,et al.  Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. , 1990, Virology.

[3]  H. Will,et al.  A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. , 1990, Journal of hepatology.

[4]  F Tsuda,et al.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.

[5]  A. Makris,et al.  Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B. , 1990, Journal of hepatology.

[6]  H. Okamoto,et al.  Quantitative and qualitative differences in serum HBV DNA between HBeAg positive carriers and those positive for anti-HBe. , 1989, The Japanese journal of experimental medicine.

[7]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[8]  G. Gasbarrini,et al.  A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy , 1989, Hepatology.

[9]  M. Brunetto,et al.  Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen , 1989, Hepatology.

[10]  Brunetto Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis , 1989 .

[11]  W. Gerlich,et al.  Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. , 1986, Virology.

[12]  F. Callea,et al.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. , 1986, Gastroenterology.

[13]  W. Rutter,et al.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Lok,et al.  Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. , 1984, Gut.

[15]  E. Keshet,et al.  Detection and characterization of hepatitis B virus DNA in serum of HBe antigen‐negative HBsAg carriers , 1984, Journal of medical virology.

[16]  D. Shafritz,et al.  Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B Virus , 2007, Hepatology.

[17]  J. Hoofnagle Chronic type B hepatitis. , 1983, Gastroenterology.

[18]  D. Vergani,et al.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. , 1982, Journal of immunology.

[19]  J. Gerin,et al.  Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liver , 1981, Hepatology.